Table 1 Demographic-, baseline,-, neuroradiological-, laboratory, treatment characteristics for all ICH patients with OAA versus non-OAA.

   Age^a (years)

71.4 (± 12.4)

69.1 (± 11.9)

0.09

   Gender^b (women)

49 (46.7%)

147 (44.5%)

0.70

Prior medical history

   Pre-mRS^c

1 (0-3)

1 (0-3)

0.14

   Hypertension^b

80 (76.2%)

261 (79.1%)

0.34

   Diabetes^b

25 (23.8%)

83 (25.2%)

0.45

   Hypercholesterolemia^b

26 (24.8%)

94 (28.5%)

0.27

   Ischemic stroke^b

28 (26.7%)

63 (19.1%)

0.10

   Hemorrhagic stroke^b

9 (8.6%)

33 (10.0%)

0.40

   Cardiac event^b

14 (13.3%)

52 (15.8%)

0.33

   Alcohol abuse^b

21 (19.6%)

60 (15.3%)

0.39

   Smoking^b

30 (28.6%)

111 (33.6%)

0.20

   Antiplatelet use^b

43 (40.9%)

118 (35.8%)

0.38

On admission status

   NIH-Stroke Scale^c

22 (15-32)

14 (5-24)

<0.01

   Glasgow Coma Scale^c

7 (3-13)

13 (7-15)

<0.01

   ICH-Score^c

3 (2-4)

1 (0-3)

<0.01

   MAP^a (mmHg)

113 (± 27.6)

116 (± 26.7)

0.51

Neuroradiological data

   Location; basalganglia^b

54 (51.4%)

158 (47.9%)

0.64

   Location; lobar^b

44 (41.9%)

131 (39.9%)

0.69

   Location; brainstem^b

5 (4.8%)

21 (6.4%)

0.55

   Location; cerebellar^b

2 (1.9%)

20 (6.1%)

0.12

   ICH volume (cm³)

48.6 (12.1-82.2)

15.0 (4.8-40.6)

<0.01

   IVH^b

74 (70.5%)

176 (53.3%)

<0.01^

   Graeb Score^c

4 (0-8)

1 (0-4)

<0.01

   Hematoma growth^b

16 (15.2%)

38 (11.5%)

0.31

   Midline shift^c(mm)

6 (2-10)

0 (0-5)

<0.01

Laboratory values on admission

   Hemoglobin^a(mmol/L)

6.93 (± 0.81)

8.97 (± 0.87)

<0.01

   Hematocrit^a

0.33 (± 0.04)

0.41 (± 0.04)

<0.01

   Leucocytes^c (10^9/L)

8.8 (6.3-12.3)

9.3 (7.2-11.7)

0.34

   Thrombocytes^c (10^9/L)

235 (153-299)

228 (193-284)

0.44

   International Normalized Ratio^a

1.05 (± 0.18)

1.01 (± 0.06)

0.07

   Partial thromboplastin time^a (s)

28.4 (± 4.3)

28.7 (± 3.7)

0.62

   Creatinine^c (μmol/L)

84.9 (64.5-102.6)

81.3 (69.0-97.3)

0.60

   C-reactive protein^c (nmol/L)

47.6 (9.5-127.6)

29.5 (10.5-76.2)

0.18

   Glucose^c (mmol/L)

7.49 (6.52-10.07)

7.38 (6.05-9.05)

0.11

In-hospital measures

   Mechanical ventilation^b

55 (52.4%)

132 (40.0%)

0.03 ^d

   Duration of ventilation^c (days)

12 (2-22)

12 (3-23)

0.33

   Pneumonia^b

70 (66.7%)

163 (49.4%)

<0.01 ^d

   Sepsis^b

16 (15.2%)

33 (10.0%)

0.14

   Urinary tract infection^b

11 (10.5%)

35 (10.6%)

0.99

   Extraventricular drainage^b

27 (25.7%)

90 (27.3%)

0.75

   Length of stay^c (days)

10 (3-20)

11 (6-18)

0.11

   In hospital mortality^b

42 (40.0%)

60 (18.2%)

<0.01